Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CD15-positive tumor-derived glioblastoma cells

ABSTRACT: CD15-positive tumor-derived glioblastoma cells

PROVIDER: PRJNA401001 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR4100990_1.fastq.gz	Fastqsanger.gz
	SRR4100990_2.fastq.gz	Fastqsanger.gz
	SRR4101000_1.fastq.gz	Fastqsanger.gz
	SRR4101000_2.fastq.gz	Fastqsanger.gz
	SRR4100991_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 66

Similar Datasets

Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity

Project description:Single cell derived clones were extracted from four glioblastoma tumors using fluorescence activated cell sorting with CD15 and CD133 markers. Unsorted bulk tumors were also derived. Gene expression analysis of clones of tumor GBM-482 involved comparison between TMZ resistant (n=5) and sensitive (n=2) clones.

2015-01-03 | E-MTAB-2693 | biostudies-arrayexpress

Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity

Project description:Single cell derived clones were extracted from four glioblastoma tumors using fluorescence activated cell sorting with CD15 and CD133 markers. Unsorted bulk tumors were also derived. Genotyping and copy number analysis was carried out for each tumor separately. Patient blood was used as control for three tumors while the fourth tumor had no blood available and a control cohort of 226 individuals was used for the latter (see Silversides, C.K., et al., Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS genetics, 2012. 8(8): p. e1002843.)

2015-01-03 | E-MTAB-2694 | biostudies-arrayexpress

Genome-wide maps of chromatin state in CD15-positive tumor-derived glioblastoma cells [ChIP-seq]

Project description:We report that these features are associated with distinct transcriptional programs, with vascular regions showing a proneural profile and hypoxic regions a mesenchymal pattern. As these regions harbor glioma stem cells (GSCs), we investigated the epigenetic regulation of these two niches. Proneural, perivascular GSCs activated EZH2, whereas mesenchymal GSCs in hypoxic regions expressed BMI1 protein. To determine the differential regional activation of EZH2 and BMI1 function, we performed chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) with H3K27me3 (histone modification by EZH2) or H2AK119Ub (histone modification by BMI1) antibodies in CD15-postive GSCs from enhancing and necrotic regions of two GBM specimens, and found over 80% of regional specific target genes displayed distinct H3K27me3 or H2AK119Ub marks, indicating distinct PRC function in GSCs residing in different regions. H3K27me3, generally associated with inhibition of transcription, marked neuronal and cellular development targets in both the enhancing and necrotic regions, albeit without substantial overlap in gene identity, with EZH2/SUZ12/H3K27me3 targets most significantly in the enhancing regions. In contrast, H2AK119Ub marked very different targets in the enhancing and necrotic regions, with H2AK119Ub in CD15-positive GSCs from the hypoxia (necrotic) regions marking genes strongly associated with mesenchymal subtype signaling pathways, such as TGFb, NFkB, and WNT, indicating probable microenvironment-specific functions of EZH2 and BMI1.

2017-10-01 | GSE103274 | GEO

Tumor-associated macrophage derived lactate remodeling glioblastoma stem cells immune microenvironment through lactylation in glioblastoma

Project description:Glioblastoma (GBM) is a malignancy with the complex tumor microenvironment (TME) dominated by glioblastoma stem cells (GSCs) and infiltrated with tumor-associated macrophages (TAMs), exhibiting aberrant metabolism progress. Lactate is a critical glycolytic metabolite that promotes tumor progression. However, the mechanism of lactate transporting and lactylation in the tumor microenvironment (TME) of GBM remains elusive. Examination of lactate metabolic signature highly expressed on TAMs and tumor cells. We uncovered that TAMs provide lactate to GSCs, promoting GSCs proliferation and inducing the non-homologous end joining (NHEJ) protein KU70 lactylated at K317. Furthermore, TAM-derived lactate-inducing KU70 lactylation inhibits cGAS- type I interferon signaling, remodeling the immunosuppressive microenvironment through reduced cytotoxic CD8+ T cell infiltration, promoting the malignant progress of GBM. This study unveils TAMs-derived lactate and lactylation as a critical regulator of NHEJ, providing fresh insights into how aberrant lactylation and TME reprogramming are linked to DNA damage repair, which contributes to exploring new therapeutic strategies for targeting lactate transporters in combination with anti-PD-1-antibody to enhance anti-tumor immunity, which provides the theoretical basis for improving the clinical prognosis of GBM.

2024-06-01 | GSE266884 | GEO

Expression data from glioblastoma derived sphere lines, adherent cell lines and their original glioblastoma tumor

Project description:Glioblastoma (GBM) derived sphere lines and adherent cell lines are an important tool for research in basic and translational neuro-oncology. Documentation of their genetic identity has become a requirement for scientific journals and grant applications to exclude cross-contamination and misidentification that lead to misinterpretation of results. Here, we report expression data for 26 samples including 4 GBM derived sphere lines (4 x 3 replicates), 2 GBM derived sphere lines passaged through intracranial transplantation (2x 1), 2 adherent GBM derived cell lines (2 + 2 x 3 replicates), 4 corresponding glioblastoma tumors and 2 non-tumor brain tissues.

2017-09-27 | GSE104291 | GEO

Gene expression profiling of patient derived glioblastoma tumor tissues

Project description:To study the gene expression profile of patient derived glioblastoma tissues and perform cross platform analysis with metabolite data derived from matching tissues

2019-12-01 | E-MTAB-7116 | biostudies-arrayexpress

Expression data from glioblastoma derived sphere lines, adherent cell lines and their original glioblastoma tumor

Project description:Expression data from glioblastoma derived sphere lines, adherent cell lines and their original glioblastoma tumor

| PRJNA412249 | ENA

Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model

Project description:Prognosis of glioblastoma remains poor despite a great deal of research. In glioblastoma, the existence of glioblastoma stem cells (GSCs) has been shown, which are responsible for tumorigenesis, invasive capacity, and therapy resistance. One of cancer stem cell markers, Leucine-rich repeat-containing G-protein coupled receptor (Lgr5) plays a role in maintenance of GSCs, however, properties of the Lgr5 positive GSCs have not been fully understood. We applied the Sleeping-Beauty transposon-induced glioblastoma model to the Lgr5-GFP transgenic mice and sorted the GFP-positive cells from the neurosphere cultures derived from the mouse glioblastoma tissues. We found that the GFP-positive GSCs exhibited higher expression of Gli2 using a global gene expression analysis. Gli2 knockdown using lentiviral-mediated shRNA downregulates both the Hedgehog- and Wnt signaling pathway-related genes including Lgr5, suppresses tumor cell proliferation and invasion capacity, and induces apoptosis. Pharmacological Gli inhibition by GANT61 also suppresses tumor cell proliferation. Furthermore, the orthotopic transplantation model revealed that silencing of Gli2 suppresses tumorigenicity of GSCs in vivo. These findings demonstrate that Gli2 affects not only Hh pathway but also Wnt pathway and plays an important role in the GSC maintenance, suggesting that Gli2 may be a potential therapeutic target for glioblastoma treatment.

2020-08-20 | GSE156522 | GEO

Homo sapiens

Project description:Genome-wide maps of chromatin state in CD15-positive tumor-derived glioblastoma cells [ChIP-seq]

| PRJNA401671 | ENA

Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model [Agilent-028005]

2020-08-25 | GSE156739 | GEO